CANCER, ISSN 0008-543X, 10/2019, Volume 125, Issue 19, pp. 3285 - 3286
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14, pp. 4025 - 4027
Journal Article
2014, Collège des Bernardins. Essai, ISBN 9782889182985, 786
Book
CANCER RESEARCH, ISSN 0008-5472, 07/2016, Volume 76, Issue 14, pp. 4025 - 4027
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 21, pp. 2086 - 2086
Journal Article
JAMA: Journal of the American Medical Association, ISSN 0098-7484, 10/2016, Volume 316, Issue 13, pp. 1359 - 1359
At least 2 women athletes subjected to intense media scrutiny in the past several years--Caster Semenya and Dutee Chand--are likely to attract additional...
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2017, Volume 114, Issue 3, pp. 474 - 479
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 4, pp. 6475 - 6482
Papillary Thyroid Carcinoma (PTC) displays one of the highest familiality scores of all cancers as measured by case-control studies, yet only a handful of...
Variants | Genetics | MiRNA | Predisposition | Thyroid | COMMON VARIANTS | genetics | thyroid | predisposition | miRNA | variants | CANCER | CELL BIOLOGY | Carcinoma, Papillary - genetics | Humans | Gene Expression Regulation, Neoplastic | Cercopithecus aethiops | MicroRNAs - metabolism | Carcinoma, Papillary - metabolism | Genetic Variation | Transfection | HEK293 Cells | Biomarkers, Tumor - metabolism | Genetic Predisposition to Disease | Risk Factors | Heredity | Carcinoma, Papillary - pathology | Thyroid Cancer, Papillary | Thyroid Neoplasms - genetics | Phenotype | Animals | Sequence Analysis, RNA | Pedigree | Biomarkers, Tumor - genetics | MicroRNAs - genetics | COS Cells | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology
Variants | Genetics | MiRNA | Predisposition | Thyroid | COMMON VARIANTS | genetics | thyroid | predisposition | miRNA | variants | CANCER | CELL BIOLOGY | Carcinoma, Papillary - genetics | Humans | Gene Expression Regulation, Neoplastic | Cercopithecus aethiops | MicroRNAs - metabolism | Carcinoma, Papillary - metabolism | Genetic Variation | Transfection | HEK293 Cells | Biomarkers, Tumor - metabolism | Genetic Predisposition to Disease | Risk Factors | Heredity | Carcinoma, Papillary - pathology | Thyroid Cancer, Papillary | Thyroid Neoplasms - genetics | Phenotype | Animals | Sequence Analysis, RNA | Pedigree | Biomarkers, Tumor - genetics | MicroRNAs - genetics | COS Cells | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology
Journal Article
Journal of medical genetics, ISSN 0022-2593, 7/2019, Volume 56, Issue 7, pp. 462 - 470
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2011, Volume 96, Issue 11, pp. 3326 - 3336
Context: Traditionally, factors predisposing to diseases are either genetic (“nature”) or environmental, also known as lifestyle-related (“nurture”). Papillary...
MIR-146A GENE | FIRST-DEGREE RELATIVES | HEPATOCELLULAR-CARCINOMA | FUNCTIONAL POLYMORPHISM | HORMONE NUCLEAR RECEPTORS | ENDOCRINOLOGY & METABOLISM | CHRONIC LYMPHOCYTIC-LEUKEMIA | SINGLE NUCLEOTIDE POLYMORPHISM | EXPRESSION PROFILES | PAPILLARY CARCINOMAS | CELL CARCINOMA | Thyroid Neoplasms - genetics | Carcinoma, Papillary - genetics | Genetic Predisposition to Disease | MicroRNAs - genetics | Signal Transduction - genetics | Humans | 100 | 500
MIR-146A GENE | FIRST-DEGREE RELATIVES | HEPATOCELLULAR-CARCINOMA | FUNCTIONAL POLYMORPHISM | HORMONE NUCLEAR RECEPTORS | ENDOCRINOLOGY & METABOLISM | CHRONIC LYMPHOCYTIC-LEUKEMIA | SINGLE NUCLEOTIDE POLYMORPHISM | EXPRESSION PROFILES | PAPILLARY CARCINOMAS | CELL CARCINOMA | Thyroid Neoplasms - genetics | Carcinoma, Papillary - genetics | Genetic Predisposition to Disease | MicroRNAs - genetics | Signal Transduction - genetics | Humans | 100 | 500
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 10/2004, Volume 4, Issue 10, pp. 769 - 780
High-penetrance mutations in several genes have been identified that contribute to hereditary colorectal cancer. The role of these mutations in cancer...
ADENOMATOUS POLYPOSIS-COLI | TUMOR SUSCEPTIBILITY ALLELE | SOMATIC G-C->T-A MUTATIONS | COMMON MSH2 MUTATION | ONCOLOGY | FOUNDER MUTATION | NON-ASHKENAZI JEWS | GERMLINE MUTATIONS | MISMATCH REPAIR | JUVENILE POLYPOSIS | I1307K APC POLYMORPHISM | Colorectal Neoplasms - epidemiology | Genetic Predisposition to Disease | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Humans | Risk Factors | Penetrance | Base Pair Mismatch | DNA Repair - genetics | Organ Specificity | Genes, APC | Neoplastic Syndromes, Hereditary - epidemiology | Colorectal Neoplasms, Hereditary Nonpolyposis - epidemiology | Neoplastic Syndromes, Hereditary - genetics | Mutation | Adenomatous Polyposis Coli - genetics | Genes, DCC | Care and treatment | Usage | Colorectal cancer | Genetic aspects | Diagnosis | Research | Genetic screening | Methods
ADENOMATOUS POLYPOSIS-COLI | TUMOR SUSCEPTIBILITY ALLELE | SOMATIC G-C->T-A MUTATIONS | COMMON MSH2 MUTATION | ONCOLOGY | FOUNDER MUTATION | NON-ASHKENAZI JEWS | GERMLINE MUTATIONS | MISMATCH REPAIR | JUVENILE POLYPOSIS | I1307K APC POLYMORPHISM | Colorectal Neoplasms - epidemiology | Genetic Predisposition to Disease | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Humans | Risk Factors | Penetrance | Base Pair Mismatch | DNA Repair - genetics | Organ Specificity | Genes, APC | Neoplastic Syndromes, Hereditary - epidemiology | Colorectal Neoplasms, Hereditary Nonpolyposis - epidemiology | Neoplastic Syndromes, Hereditary - genetics | Mutation | Adenomatous Polyposis Coli - genetics | Genes, DCC | Care and treatment | Usage | Colorectal cancer | Genetic aspects | Diagnosis | Research | Genetic screening | Methods
Journal Article
Proceedings of the National Academy of Sciences, USA, ISSN 0027-8424, 01/2017, Volume 114, Issue 3, pp. 474 - 474
A locus on chromosome 9q22 harbors a SNP (rs965513) firmly associated with risk of papillary thyroid carcinoma (PTC). The locus also comprises the forkhead box...
Journal Article
ENDOKRYNOLOGIA POLSKA, ISSN 0423-104X, 2019, Volume 70, Issue 5, pp. 423 - 429
The genetic risk of differentiated thyroid cancer (DTC) probably consists of multiple low-penetrance, single-nucleotide polymorphisms (SNP). Such markers are...
COMMON VARIANTS | FIRST-DEGREE RELATIVES | GWAS | SUSCEPTIBILITY LOCI | RISK | GENETIC-VARIANTS | RET PROTOONCOGENE | ENDOCRINOLOGY & METABOLISM | genetic predisposition | FACTOR-H POLYMORPHISM | papillary thyroid carcinoma | genome-wide association studies | CARCINOMA | EXPRESSION | PTC | GENOME-WIDE ASSOCIATION
COMMON VARIANTS | FIRST-DEGREE RELATIVES | GWAS | SUSCEPTIBILITY LOCI | RISK | GENETIC-VARIANTS | RET PROTOONCOGENE | ENDOCRINOLOGY & METABOLISM | genetic predisposition | FACTOR-H POLYMORPHISM | papillary thyroid carcinoma | genome-wide association studies | CARCINOMA | EXPRESSION | PTC | GENOME-WIDE ASSOCIATION
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3380 - 3387
Microsatellite instability (MSI) is a clonal change in the number of repeated DNA nucleotide units in microsatellites. It arises in tumors with deficient...
COLON-CANCER | ADJUVANT CHEMOTHERAPY | BETHESDA GUIDELINES | DNA MISMATCH REPAIR | LYNCH-SYNDROME | ONCOLOGY | HMLH1 PROMOTER HYPERMETHYLATION | YOUNG-PATIENTS | REPLICATION ERRORS | MONONUCLEOTIDE REPEATS | CELL-LINES | Colorectal Neoplasms - therapy | Microsatellite Instability | Prognosis | Colorectal Neoplasms - genetics | DNA Mismatch Repair | Humans | Polymerase Chain Reaction | Genetic Markers | Bon | Biology of Neoplasia | Gic7
COLON-CANCER | ADJUVANT CHEMOTHERAPY | BETHESDA GUIDELINES | DNA MISMATCH REPAIR | LYNCH-SYNDROME | ONCOLOGY | HMLH1 PROMOTER HYPERMETHYLATION | YOUNG-PATIENTS | REPLICATION ERRORS | MONONUCLEOTIDE REPEATS | CELL-LINES | Colorectal Neoplasms - therapy | Microsatellite Instability | Prognosis | Colorectal Neoplasms - genetics | DNA Mismatch Repair | Humans | Polymerase Chain Reaction | Genetic Markers | Bon | Biology of Neoplasia | Gic7
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 301 - 301
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2008, Volume 105, Issue 20, pp. 7269 - 7274
Although papillary thyroid carcinoma (PTC) displays strong heritability, no predisposing germ-line mutations have been found. We show that a common G/C...
MicroRNA | Thyroid cancer | Papillary carcinoma | RNA | Plasmids | DNA | Genetic mutation | Genotypes | Tumors | Cancer | Genetic predisposition | miR-146 | microRNA processing | Polymorphism | LOCALIZATION | ACTIVATION | MULTIDISCIPLINARY SCIENCES | polymorphism | thyroid cancer | MICRORNAS | GENE | BRAF MUTATIONS | genetic predisposition | HUMAN CANCERS | NF-KAPPA-B | Genetic Predisposition to Disease | Humans | Thyroid Neoplasms - etiology | Genotype | MicroRNAs - biosynthesis | MicroRNAs - metabolism | Carcinoma - etiology | Case-Control Studies | Thyroid Neoplasms - genetics | Transfection | Alleles | Cell Line, Tumor | Carcinoma - genetics | MicroRNAs - genetics | Polymorphism, Single Nucleotide | Mutation | Cohort Studies | Influence | Development and progression | Genetic aspects | Single nucleotide polymorphisms | Research | Gene expression | RNA processing | Identification and classification | Methods | Biological Sciences
MicroRNA | Thyroid cancer | Papillary carcinoma | RNA | Plasmids | DNA | Genetic mutation | Genotypes | Tumors | Cancer | Genetic predisposition | miR-146 | microRNA processing | Polymorphism | LOCALIZATION | ACTIVATION | MULTIDISCIPLINARY SCIENCES | polymorphism | thyroid cancer | MICRORNAS | GENE | BRAF MUTATIONS | genetic predisposition | HUMAN CANCERS | NF-KAPPA-B | Genetic Predisposition to Disease | Humans | Thyroid Neoplasms - etiology | Genotype | MicroRNAs - biosynthesis | MicroRNAs - metabolism | Carcinoma - etiology | Case-Control Studies | Thyroid Neoplasms - genetics | Transfection | Alleles | Cell Line, Tumor | Carcinoma - genetics | MicroRNAs - genetics | Polymorphism, Single Nucleotide | Mutation | Cohort Studies | Influence | Development and progression | Genetic aspects | Single nucleotide polymorphisms | Research | Gene expression | RNA processing | Identification and classification | Methods | Biological Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 26, pp. 2509 - 2520
Persons with mismatch repair–deficient tumors are more likely than persons with mismatch repair–proficient tumors to benefit from pembrolizumab — which...
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands
Journal Article